EP Lab Digest

#

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

CLINICAL EVENTS CALENDAR

  • Wednesday, September 10, 2008 - 00:50
    Certificate Course in Cardiac EP for Allied Professionals (Module C)
    http://www.cepia.com.au
  • Thursday, September 11, 2008 - 14:42
    Arrhythmias in the Real World 2008
    http://www.acc.org
  • Thursday, September 11, 2008 - 14:45
    EP in Aspen VI
    http://www.southerncoloradoheartinstitute.com
  • Friday, September 12, 2008 - 14:47
    The 14th Annual South Atlantic Society of Electrophysiology for Allied Professionals (SASEAP) Workshop
    http://www.saseap.org

Ventricular Fibrillation

Electrocautery-Induced Ventricular Tachycardia and Fibrillation during Device Implantation and Explantation

Electrocautery-induced ventricular tachycardia.
VOLUME: 7 PUBLICATION DATE: Feb 01 2007

Electrocautery has long been described to generate electromagnetic interference (EMI) and oversensing by implanted pacemakers and defibrillators. Electrocautery is commonly used during surgical procedures involving implantation and explantation of pacemakers and implantable cardioverters-defibrillator (ICDs). However, ventricular tachycardia (VT) or ventricular fibrillation (VF) occurring as a result of electrocautery has only been sporadically reported. We present 4 cases of electrocautery-associated VT or VF during either implantation or explantation of ICDs and pacemakers. The etiology of VT/VF is unclear in these circumstances. Methods This retrospective study was approved by the Institutional Review Board at Winthrop University Hospital. During the period of November 2000 to March 2006, 4,698 pacemakers and implantable defibrillators were implanted and/or explanted at Winthrop University Hospital.

Wearable Defibrillators: A New Tool in the Management of Ventricular Tachycardia/Ventricular Fibrillation

The external wearable system consists of: 1) monitor; 2) response buttons; 3) ECG electrodes; 4) therapy electrodes.ECG strip recording transmitted via a phone line showing wide complex tachycardia at 192 beats per minute. Note simultaneous recording of two channels available from the manufacturer’s website.
VOLUME: 5 PUBLICATION DATE: Dec 01 2005

High risk patients, who do not qualify for an implantable cardioverter-defibrillators, run a risk of ventricular arrhythmia and sudden cardiac death. However, if a new ICD cannot be implanted due to surgical contraindications, recent revascularization (within three months) or recent diagnosis of dilated cardiomyopathy (three to nine months), or an ICD has been explanted due to infection, a wearable defibrillator (WCD) provides an option for some protection against sudden cardiac death.

REVIEW OUR OTHER
CARDIOLOGY BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Cath Lab Digest
  • Journal Of Invasive Cardiology
  • Vascular Disease Management
  • Cath Lab Basics